Novavax
NVAXNovavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu an …
© Wikipedia /
Creative Commons CC-BY-SA 3.0
more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Novavax
Subscribe RSS| Date | Type | Ø-Price | Volume |
|---|---|---|---|
| 12/31/2024 | Sell | $8.0 | $43,200 |
| 12/24/2024 | Sell | $8.5 | $39,008 |
| 12/13/2024 | Sell | $9.0 | $37,435 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)